Financial results - CYTEKA LABORATORIES SRL

Financial Summary - Cyteka Laboratories Srl
Unique identification code: 37872750
Registration number: J2017003396230
Nace: 6392
Sales - Ron
54.878
Net Profit - Ron
23.492
Employees
Open Account
Company Cyteka Laboratories Srl with Fiscal Code 37872750 recorded a turnover of 2024 of 54.878, with a net profit of 23.492 and having an average number of employees of - . The company operates in the field of Alte activităţi de servicii informaţionale n.c. a having the NACE code 6392.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Cyteka Laboratories Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - 4.075 5.317 16.769 418 45.504 52.515 44.069 54.878
Total Income - EUR - - 4.075 5.317 16.810 577 45.623 52.616 44.070 54.908
Total Expenses - EUR - - 2.195 6.120 2.890 6.688 9.455 25.747 42.871 27.669
Gross Profit/Loss - EUR - - 1.880 -803 13.920 -6.112 36.168 26.870 1.199 27.239
Net Profit/Loss - EUR - - 1.757 -963 13.502 -6.127 34.801 25.294 759 23.492
Employees - - 0 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 25.2%, from 44.069 euro in the year 2023, to 54.878 euro in 2024. The Net Profit increased by 22.737 euro, from 759 euro in 2023, to 23.492 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Cyteka Laboratories Srl

Rating financiar

Financial Rating -
CYTEKA LABORATORIES SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Cyteka Laboratories Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Cyteka Laboratories Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Cyteka Laboratories Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Cyteka Laboratories Srl - CUI 37872750

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - 0 0 0 1.381 1.325 22.873 22.448 23.695
Current Assets - - 1.973 2.224 16.121 6.049 35.845 43.296 27.959 68.193
Inventories - - 0 0 0 0 0 0 0 0
Receivables - - 0 0 6.871 0 3.002 499 1.461 750
Cash - - 1.973 2.224 9.249 6.049 32.844 42.796 26.498 67.442
Shareholders Funds - - 1.823 827 14.313 7.915 42.541 67.967 68.519 91.628
Social Capital - - 66 64 63 62 61 61 202 201
Debts - - 150 1.397 1.808 1.421 1.323 1.614 374 2.720
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "6392 - 6392"
CAEN Financial Year 6201
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 68.193 euro in 2024 which includes Inventories of 0 euro, Receivables of 750 euro and cash availability of 67.442 euro.
The company's Equity was valued at 91.628 euro, while total Liabilities amounted to 2.720 euro. Equity increased by 23.492 euro, from 68.519 euro in 2023, to 91.628 in 2024.

Risk Reports Prices

Reviews - Cyteka Laboratories Srl

Comments - Cyteka Laboratories Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.